The pharmaceutical and healthcare market reported 418 deals worth $43.8 billion in November 2022. The Pharmaceuticals Industry Deals and Trends report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceutical industry in November 2022.

For more deal type insights into the pharmaceuticals market, download a free report sample

Explore the dynamic landscape of the pharmaceuticals industry with our in-depth analysis on deals and trends. Uncover the latest mergers, acquisitions, and collaborations shaping the sector. From groundbreaking research partnerships to strategic business alliances, discover the driving forces propelling innovation in pharmaceuticals.

Pharmaceuticals Market Segmentation by Therapy Areas

The key therapy areas in the pharmaceuticals and healthcare market are oncology, central nervous system, infectious disease, immunology, metabolic disorders, gastrointestinal, and cardiovascular. The oncology therapeutics market recorded the majority of equity offering deals, followed by the central nervous system therapeutics market. 

Pharmaceuticals Market Segmentation by Regions

The key regions in the pharmaceuticals and healthcare market are North America, Europe, Asia Pacific, and the rest of the world. North America reported an increase in the number of deals and in deal value in November 2022.

Pharmaceuticals Market Segmentation by Deal Types

The key deal types in the pharmaceuticals and healthcare market are capital raising (equity/debt offerings), PE/VC, M&A, partnerships, and licensing agreements. PE/VC segment and capital raisings (equity and debt offerings) segment recorded the highest number of deals each.